Booz Allen Commercial delivers advanced cyber defenses to the Fortune 500 and Global 2000. We are technical practitioners and cyber-focused management consultants with unparalleled experience – we know how cyber-attacks happen and how to defend against them.
Our strategy and technology consultants have empowered our international clients with the knowledge and experience they need to build their own local resources and capabilities.
In facing challenges of modernization, our Middle East and North Africa clients have complex requirements that benefit from our proven experience in guiding major programs and projects for governments and private-sector organizations. The services we offer in UAE, Qatar, Egypt, Turkey, Kuwait, Morocco, Jordan, and other regional countries build on our consulting legacy.
Our clients call upon us to work on their hardest problems—delivering effective health care, protecting warfighters and their families, keeping our national infrastructure secure, bringing into focus the traditional boundaries between consumer products and manufacturing as those boundaries blur.
Booz Allen was founded on the notion that we could help companies succeed by bringing them expert, candid advice and an outside perspective on their business. The analysis and perspective generated by that talent can be found in the case studies and thought leadership produced by our people.
Learn more about Booz Allen's diverse culture and environment of inclusion that fosters respect and opportunity for all employees.
We've come a long way delivering innovative solutions. But our next chapter is still being written.
Our 22,600 engineers, scientists, software developers, technologists, and consultants live to solve problems that matter. We’re proud of the diversity throughout our organization, from our most junior ranks to our board of directors and leadership team.
Booz Allen takes pride in a culture that encourages and rewards the many dimensions of leadership—innovative thinking, active collaboration, and personal service. We’re particularly proud of the diversity of our Leadership Team and Board of Directors, among the most diverse in corporate America today.
An ever-expanding landscape of new medical products and therapies demands an equally fast-moving evolution of regulatory actions and policy. From brand new drugs to insulin delivery devices and cancer screening equipment, agencies including the Food & Drug Administration and the Center for Drug Evaluation & Research face the challenges of rapidly evolving science and technology.
And these new therapies and medical products are increasingly complex in their development, manufacture, and regulation. New laws and national standards that reduce risks and improve transparency can sometimes slow the process. We're working to keep that process smooth.
Regulatory science is what we call the study of developing and enhancing tools, techniques, and policy that informs regulatory actions, ultimately to promote public health. Read about our approach, our case studies, and our dedication to advancing medicine in the Regulatory Science Playbook.
Our Playbook defines regulatory science, lays out the challenges faced by today’s regulatory agencies, and offers examples of how to solve them.